FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hikma Injectables USA Inc. | 117939054 | 63037-155 | 63037-155-25 | Rocuronium Bromide | 50 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-156 | 63037-156-25 | Rocuronium Bromide | 100 mg/10 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-117 | 63037-117-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-119 | 63037-119-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 50 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-125 | 63037-125-25 | Glycopyrrolate | 1 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 50 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 50 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 100 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-162 | 63037-162-25 | Lidocaine Hydrochloride Anhydrous | 50 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 5 mg/5 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2500 ug/250 mL | 2024-1 | valid | 2026-11-08 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-100 | 63037-100-05 | Fentanyl Citrate | 1000 ug/100 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5222 | 26436-5222-2 | "2,3-Dimercaptosuccinic Acid" | 250 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5233 | 26436-5233-3 | Nystatin | 100000 U/1 g | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5233 | 26436-5233-6 | Nystatin | 100000 U/1 g | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5007 | 26436-5007-3 | Panthenol | 250 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 20 ug/1 mL; 2 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5097 | 26436-5097-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5183 | 26436-5183-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5232 | 26436-5232-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 20 mg/1 mL; 5 ug/1 mL; .5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5112 | 26436-5112-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 60 ug/1 mL; 3 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5497 | 26436-5497-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 30 mg/1 mL; 30 ug/1 mL; 2 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5145 | 26436-5145-5 | Papaverine Hydrochloride; Phentolamine Mesylate | 30 mg/1 mL; 2 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5200 | 26436-5200-6 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 60 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5580 | 26436-5580-1 | Phenol | 50 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5433 | 26436-5433-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 40 mg/1 g; 80 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 200 mg/1 g; 20 mg/1 g; 80 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5526 | 26436-5526-0 | "phenylephrine Hydrochloride, (+/-)-; Tropicamide; Cyclopentolate" | 25 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-6001 | 26436-6001-1 | Potassium Chloride | .2 meq/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5078 | 26436-5078-1 | Potassium Chloride | 2 meq/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5465 | 26436-5465-3 | Prasterone; Estriol | 10 mg/1 g; 10 mg/1 g | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-6028 | 26436-6028-3 | Procaine Hydrochloride | 20 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-1124 | 26436-1124-1 | Progesterone | 200 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5248 | 26436-5248-1 | Progesterone | 125 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5617 | 26436-5617-1 | Progesterone | 25 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5152 | 26436-5152-1 | Progesterone | 150 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5062 | 26436-5062-1 | Progesterone | 50 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5002 | 26436-5002-1 | Pyridoxine Hydrochloride | 100 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5056 | 26436-5056-3 | Riboflavin 5'-Phosphate Sodium | 5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5471 | 26436-5471-3 | Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2 mg/1 mL; 100 mg/1 mL; 2 mg/1 mL; 100 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5608 | 26436-5608-2 | Semaglutide | 2.5 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5424 | 26436-5424-1 | Sermorelin Acetate | 300 ug | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5607 | 26436-5607-9 | Sermorelin Acetate | 1 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5613 | 26436-5613-1 | Tadalafil | 12 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5086 | 26436-5086-1 | Tadalafil | 25 mg | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5024 | 26436-5024-3 | Taurine | 50 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5084 | 26436-5084-3 | Biotin | 10 mg/1 mL | 2024-1 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5541 | 26436-5541-1 | Boric Acid | 600 mg | 2024-1 | valid | 2026-11-08 |